Paradigm Capital
 
Paradigm Home
News
About Paradigm
Paradigm Research
Investment Banking
Sales and Trading
 

Please note: Login required to access reports.

Search by
Start typing in the Ticker or Company Name field to find a company.
 
Ticker
Company Name
Analyst
Industry
Date to (YYYY-MM-DD)
 
Search Results - Alphabetical: 'O' 408 articles found:

RHE/RHEO - Occulogix Inc.
2006-03-10   RHE - Making a Comeback Versus Placebo
2006-02-06   RHE - Quite a surprise - Muddy Results
2006-01-12   Health Care Sector - Looking for the Next Stars: Our picks - Biovail, Occulogix and Transition Therapeutics
2005-05-06   RHE - Getting Ready for FY06-No Change to our Investment Thesis
2005-01-31   RHE - No more Mud in your Blood, Get a Blood Filter Job

ONC - Oncolytics Biotech
2015-12-16   ONC - Discontinuing Coverage
2015-03-05   ONC - Under Review
2014-09-17   ONC - Results from Phase II Pancreatic Cancer Study Are Mixed
2014-04-09   ONC - Releases Further Analysis of Head & Neck Data
2014-03-14   ONC - Uneventful 2013 Results; Upcoming Randomized Data Is Key
2014-02-28   ONC - Share Purchase Agreement = Balance Sheet Insurance
2013-11-22   ONC - H&N Results Warrant Further Study, Valuable Info Learned
2013-10-29   ONC - Positive Results from Phase II Lung Trial
2013-07-12   ONC - Risk/Reward Skewed to the Upside
2013-03-06   ONC - Funding Provides Runway for Multiple Shots on Goal
2013-02-11   ONC - Further Support for REOLYSIN in a Pre-Surgical Role
2012-12-14   ONC - Activity of REOLYSIN Confirmed by Randomized Data
2012-11-12   ONC - Positive Data from Lung and Pancreatic Cancer Trials
2012-09-13   ONC - Decision to Alter Phase III Program a Prudent Choice
2012-07-09   ONC - Ahead of the Data — Reviewing REOLYSIN’s Potential

  Page 1 of 21   Next

Research Disclosures

RESEARCH RESULTS TAILORED TO FIT

Get just what you need -- just when you need it. That’s what our search tools allow you to do. The latest information or something from our archives. Find it easily. Find it here.


INVESTMENT BANKING SALES AND TRADING PARADIGM CAPITAL RESEARCH